Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naoxueshu oral liquid in spontaneous intracerebral hemorrhage
ChiCTR2100051271Phase 4Recruiting
- Sponsor
- North China University of Science and Technology Affiliated Hospital
- Start
- Nov 2021
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of naoxueshu in intracerebral hemorrhage (ICH) (4 arms), sponsored by North China University of Science and Technology Affiliated Hospital. Primary endpoints: Volume of hematomas, Severity of brain edema and 1 more. Started Nov 2021; status: recruiting.
02
Drugs
naoxueshu
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR2100051271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051271.